Skip to main content
Log in

Retinoids inhibit phospholipase A2 in human synovial fluid and arachidonic acid release from rat peritoneal macrophages

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Retinoids have demonstrated antiinflammatory activity in certain animal models and human disease states. The mechanism by which retinoids elicit this activity is unknown. Some retinoids are known to inhibit arachidonic acid (AA) release and metabolism in intact cells in vitro. Retinoids may exert their antiinflammatory effects by inhibiting phospholipase A2 (PLA2) and the resultant production of inflammatory AA metabolites. Retinoids were evaluated in vitro as inhibitors of the PLA2 activity in human synovial fluid (HSF-PLA2). Of the naturally occurring, nonaromatic retinoids tested, all-trans-retinal, all-trans-retinoic acid (all-trans-RA) and 13-cis-RA were the most potent inhibitors (IC50 s 6–15ΜM), whereas all-trans-retinol was much less potent. Of the synthetic aromatic retinoids and arotinoids examined, the free carboxylic, sulfonic, and sulfinic acid forms were more than 15-fold more potent inhibitors of HSF-PLA2 than their corresponding ethyl esters. These retinoids also were evaluated as inhibitors of calcium ionophore A23187-induced AA release from rat peritoneal macrophages. All-trans-RA and 13-cis-RA were potent inhibitors of AA release from these cells (IC50 s 4ΜM), while the other natural retinoids were inactive. Of the aromatic retinoids and arotinoids tested, the free acid forms (IC50 s 2–6ΜM) were 5- to 21-fold more potent inhibitors of AA release from the macrophages than their corresponding ethyl esters. The potencies of the arotinoids as inhibitors of HSF-PLA2 appeared to correlate with their potencies as inhibitors of AA release from A23187-stimulated rat peritoneal macrophages. These data support the hypothesis that one possible mechanism for the known antiinflammatory activity of some retinoids may be by inhibition of phospholipase A2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brinckerhoff, C. E., J. W. Coffey, andA. C. Sullivan. 1983. Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid.Science 221:756–758.

    Google Scholar 

  2. Haraoui, B., R. L. Wilder, J. B. Allen, M. B. Sporn, R. K. Helfgott, andC. E. Brinck-Erhoff. 1985. Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide of streptococcal cell wall-induced arthritis in rats.Int. J. Immunopharmacol. 7:903–916.

    Google Scholar 

  3. Orfanos, C. E., andR. Bauer. 1983. Evidence for antiinflammatory activity of oral and synthetic retinoids: Experimental findings and clinical experience.Br. J. Dermatol. 109 (Suppl. 25):55–60.

    Google Scholar 

  4. Smith, E. L., andJ. J. Tegeler. 1989. Advances in dermatology.Annu. Rep. Med. Chem. 24:177–196.

    Google Scholar 

  5. Nigam S., S.Müller, and R.Stadler. 1988. Arotinoids as inhibitors of arachidonic acid (AA) release and metabolism in human blood cells. Taipei Conference on Prostaglandin and Leukotriene Research. Abstract S115.

  6. Vane, J. R. 1972. Prostaglandins in the inflammatory response.In Inflammation: Mechanisms and Control. I. H. Lepow and P. A. Ward, editors. Academic Press, New York, 261–279.

    Google Scholar 

  7. Pruzanski, W., E. C. Keystone, C. Bombardier, K. M. Snow, andP. Vadas. 1987. Phospholipase A2 correlates with disease activity in rheumatoid arthritis.Arthritis Rheum. 30:S114 (Abstract E11).

    Google Scholar 

  8. Roenigh, H. H. 1987. Retinoids: Experimental and clinical results, general introduction.Dermatologica 175(Suppl. 1):5–7.

    Google Scholar 

  9. Fawzy, A. A., andR. C. Franson. 1986. Purification and characterization of human synovial fluid phospholipase A2.Biophys. J. 49:533a.

    Google Scholar 

  10. Hope, W. C., B. J.Patel, and G. A.Wiggan. 1988. Retinoids as inhibitors of human synovial fluid phospholipase A2. Inflammation Research Association Meeting, Therapeutic Control of Inflammatory Diseases, White Haven, Pennsylvania. October 23–27, Abstract 133.

  11. Fiedler-Nagy, C., B. H. Wittreich, A. Georgiadis, W. C. Hope, A. F. Welton, andJ. W. Coffey. 1987. Comparative study of natural and synthetic retinoids as inhibitors of arachidonic acid release and metabolism in rat peritoneal macrophages.Dermatologica 175(Suppl. 1):81–92.

    Google Scholar 

  12. Fawzy, A. A., B. S. Vishwanath, andR. C. Franson. 1988. Inhibition of human nonpancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action.Agents Actions 25:394–400.

    Google Scholar 

  13. Wallach, D. P., andV. J. R. Brown. 1981. Studies on the arachidonic acid cascade-I. Inhibition of phospholipase A2 in vitro and in vivo by several novel series of inhibitor compounds.Biochem. Pharmacol. 30:1315–1324.

    Google Scholar 

  14. Vargaftig, B. B., andN. Dao Hai. 1972. Selective inhibition by mepacrine of the release of “rabbit aorta contracting substanceℍ evoked by the administration of bradykinin.J. Pharm. Pharmacol. 62:79–89.

    Google Scholar 

  15. Volwerk, J. J., W. A. Pieterson, andG. H. Dehaas. 1974. Histidine at the active site of phospholipase A2.Biochemistry 13:1446–1454.

    Google Scholar 

  16. Lombardo, D., andE. A. Dennis. 1985. Cobra venom phospholipase A2 inhibition by manoalide. A novel type of phospholipase A2 inhibitor.J. Biol. Chem. 260:7234–7240.

    Google Scholar 

  17. Fiedler-Nagy, C., A. Georgiadis, andJ. W. Coffey. 1985. Effects of retinoids on arachidonic acid release and metabolism by rat peritoneal macrophages.Agents Actions 16:620–621.

    Google Scholar 

  18. Hope, W. C., B. J.Patel, C.Fiedler-Nagy, B. H.Wittreich, and A. F.Welton. 1989. Comparison of retinoids as inhibitors of phospholipase A2 in human synovial fluid and of arachidonic acid release from rat peritoneal macrophages. Presented at the 1989 Winter Prostaglandin Conference, Keystone, Colorado, January.

  19. Bray, M. A. 1984. Retinoids are potent inhibitors of the generation of rat leukocyte leukotriene B4-like activity in vivo.Eur. J. Pharmacol. 98:61–67.

    Google Scholar 

  20. Nigam, S. 1987. Inhibition of lipoxygenase products by retinoids in human blood cells.Dermatologica 175(Suppl. 1):73–80.

    Google Scholar 

  21. Franson, R., R. Dobrow, J. Weiss, P. Elsbach, andW. B. Weglicki. 1978. Isolation and characterization of a phospholipase A2 from an inflammatory exudate.J. Lipid Res. 19:18–23.

    Google Scholar 

  22. Bligh, E. G., andW. J. Dyer. 1959. A rapid method of total lipid extraction and purification.Can. J. Biochem. Physiol. 37:911–917.

    Google Scholar 

  23. Vadas, P., E. Stefanski, andW. Pruzanski. 1986. Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2.Inflammation 10:183–193.

    Google Scholar 

  24. Fawzy, A. A., R. Dobrow, andR. C. Franson. 1987. Modulation of phospholipase A2 activity in human synovial fluid by cations.Inflammation 11:389–400.

    Google Scholar 

  25. Jacobson, P., L. Marshall, M. Amy Sung, andR. Jacobs. 1989. Inactivation of human synovial fluid phospholipase A2 by manoalide.FASEB J. 3:A595.

    Google Scholar 

  26. Mobilio, D., andL. A. Marshall. 1989. Recent advances in the design and evaluation of inhibitors of phospholipase A2.Annu. Rep. Med. Chem. 24:157–166.

    Google Scholar 

  27. Geiger, J.-M., andC. J. Brindley. 1988.cis-trans Interconversion of acitretin in man.Skin Pharmacol 1:230–236.

    Google Scholar 

  28. Nakano, T., K. Hanasaki, S. Matsumoto, andH. Arita. 1988. Retinol induces platelet aggregation via activation of phospholipase A2.Biochem. Biophys. Res. Commun. 154:1075–1080.

    Google Scholar 

  29. Stillwell, W., M. Ricketts, H. Hudson, andS. Nahmias. 1982. Effect of retinol and retinoic acid on permeability, electrical resistance and phase transition of lipid bilayers.Biochem. Biophys. Acta 688:653–659.

    Google Scholar 

  30. Langsford, C. A., M. R. Albrecht, T. M. Phelps, W. Stillwell, andS. R. Wassall. 1987.Biophys. J. 51:239a.

    Google Scholar 

  31. Smythies, J. 1980. Prostaglandins and cancer: Further stereochemical studies on the molecule of phospholipase A2.Psychoneuroendocrinology 5:353–358.

    Google Scholar 

  32. Cantelmi, A., A. Gaiti, G. Porcellati, V. Ansidei, andM. Binazzi. 1982. Modulation of phospholipase A activity in psoriatic skin.Farmaco Ed. Sci. 37:612–617.

    Google Scholar 

  33. Marcelo, C., L. Rhodes, andS. Bulengo. 1988. Epidermal keratinocyte phospholipase A2 and C: Characterization and effect of steroids and retinoids.Clin. Res. 36:671A.

    Google Scholar 

  34. Marcelo, C., R. Bartel, andJ. Fortune. 1986. Effect of retinoids and glucocorticoids on phospholipase A2 and C mediated release of arachidonic acid by murine keratinocyte cultures.Clin. Res. 34:766A.

    Google Scholar 

  35. Punnonen, K., T. Puustinen, andC. Jansén. 1986. The effect of the antipsoriatic drug metabolite etretin (Ro 10-1670) on UVB irradiation induced changes in the metabolism of arachidonic acid in human keratinocytes in culture.Photochem. Photobiol. 44:623–267.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hope, W.C., Patel, B.J., Fiedler-Nagy, C. et al. Retinoids inhibit phospholipase A2 in human synovial fluid and arachidonic acid release from rat peritoneal macrophages. Inflammation 14, 543–559 (1990). https://doi.org/10.1007/BF00914275

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00914275

Keywords

Navigation